ReviewNutrition & metabolism2025
High-fat diet, intestinal microecology and bone loss.
Review in Nutrition & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Intestinal-Bone Axis Mediated byMicroorganisms · 2026Review
- Osteoporosis from the perspective of the gut-bone axis: gut microbiota, metabolites, and multi-system synergistic regulation.Journal of endocrinological investigation · 2026Review
- Dietary Microplastics Engage Gut Mechanosensory-Endocrine Signaling to Disrupt Bone Homeostasis.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Bone, a vital component of the human body, plays a crucial role in maintaining mobility and systemic health. Growing evidence underscores the complex interplay between a high-fat diet (HFD), intestinal microecology, and bone loss. This review consolidates findings across three interconnected mechanisms: (1) HFD compromises bone homeostasis by reducing bone mineral density (BMD) and disrupting microarchitecture, driven by bone marrow adiposity, oxidative stress, and chronic inflammation; (2) HFD disrupts intestinal microecology through microbiota dysbiosis (e.g., elevated Firmicutes/Bacteroidetes ratio, depletion of Bifidobacterium), epithelial barrier impairment (e.g., suppressed Mucin2 secretion, downregulated tight junction proteins), and immune dysregulation (e.g., Th17/Treg imbalance, diminished IL-10 production); and (3) intestinal microecology imbalances exacerbate bone loss through microbial metabolite alterations (e.g., a deficiency of short-chain fatty acids impairing Treg-mediated Wnt10b signaling), systemic inflammation from barrier leakage, and intestinal immune cell trafficking (e.g., Th17 migration to bone marrow). These interconnected mechanisms point to an indirect pathway by which HFD contributes to bone loss through alterations in intestinal microecology. While this indirect relationship remains insufficiently validated, accumulating evidence highlights the important roles of HFD and intestinal microecology in bone regulation. This review aims to comprehensively examine the connections between HFD, intestinal microecology, and bone loss, with a focus on elucidating these potential mechanisms. Given diet's profound impact on intestinal microecology, optimizing dietary patterns to rebalance intestinal microecology offers a promising strategy for preventing and treating bone-related disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.